NCT03713931 (IPUMA2) is a clinical trial of PUMA Score questionnaire in Adult, sponsored by Gustavo Zabert, MD.

Who is sponsoring NCT03713931?

NCT03713931 is sponsored by Gustavo Zabert, MD.

What drugs are being tested in NCT03713931?

Interventions in NCT03713931: PUMA Score questionnaire.

What condition does NCT03713931 study?

NCT03713931 studies Adult, Risk Factors, Primary Care, COPD, Screening Score, Spirometry, Diagnosis.

Is NCT03713931 still recruiting?

NCT03713931 is currently status unknown. Last updated 27 December 2018.

Last reviewed 2018-12-27 · How we verify

NCT03713931: IPUMA2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PUMA Implementation 2

Status unknown Last updated 27 December 2018

What this trial tests

trial testing PUMA Score questionnaire in Adult in 1,000 participants. Status unknown.

Timeline

14 November 2018

Primary endpoint
21 December 2018

21 January 2019

Quick facts

Lead sponsor	Gustavo Zabert, MD
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	14 November 2018
Primary completion	21 December 2018
Estimated completion	21 January 2019
Sites	5 locations across Argentina

Drugs / interventions tested

PUMA Score questionnaire

Conditions studied

Adult — all drugs for Adult →
Risk Factors — all drugs for Risk Factors →
Primary Care — all drugs for Primary Care →
COPD — all drugs for COPD →

Sponsor

Gustavo Zabert, MD

Who can join

Adults 40 to 90, any sex, with Adult or Risk Factors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

COPD is underdiagnosed and spirometry is not widely available in primary care settings. This study explore the value of PUMA´s questionnaire in a case finding strategy to detect patients to perform spirometry in a real world scenario of primary care health venues.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adult

Currently open trials in the same condition.

NCT07354607 — Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow · NA · recruiting
NCT07163728 — Leptin: A Marker for AML Chemo-Sensitivity · recruiting
NCT07035171 — CABGpreHAB - a Feasibility Study Protocol · NA · recruiting
NCT07018518 — PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma · Phase 1 · recruiting
NCT06883149 — PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03713931 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gustavo Zabert, MD
Last refreshed: 27 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03713931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing